Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Elpida
2. N-(4-((2-(4-bromo-3-(3-chloro-5-cyanophenoxy)-2-fluorophenyl)acetyl)amino)-3-chlorophenyl)sulfonylpropanamide
3. R-1206
4. R1206
1. 868046-19-9
2. Elsulfavirine [inn]
3. Zc4cgo0rug
4. 2-fluorophenyl]acetamido}-
5. R-1206
6. 3-chlorobenzenesulfonyl)propanamide
7. N-((4-(2-(4-bromo-3-(3-chloro-5-cyanophenoxy)-2-fluorophenyl)acetamido)-3-chlorophenyl)sulfonyl)propionamide
8. N-(4-{2-[4-bromo-3-(3-chloro-5-cyanophenoxy)-
9. Benzeneacetamide, 4-bromo-3-(3-chloro-5-cyanophenoxy)-n-(2-chloro-4-(((1-oxopropyl)amino)sulfonyl)phenyl)-2-fluoro-
10. N-(4-((2-(4-bromo-3-(3-chloro-5-cyano-phenoxy)-2-fluoro-phenyl)acetyl)amino)-3-chloro-phenyl)sulfonylpropanamide
11. Unii-zc4cgo0rug
12. Elsulfavirine [who-dd]
13. Schembl1341521
14. Chembl4301163
15. At14358
16. Db14929
17. Hy-109056
18. Cs-0031646
19. N-[4-[[2-[4-bromo-3-(3-chloro-5-cyanophenoxy)-2-fluorophenyl]acetyl]amino]-3-chlorophenyl]sulfonylpropanamide
| Molecular Weight | 629.3 g/mol |
|---|---|
| Molecular Formula | C24H17BrCl2FN3O5S |
| XLogP3 | 5.2 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 8 |
| Exact Mass | 626.94334 g/mol |
| Monoisotopic Mass | 626.94334 g/mol |
| Topological Polar Surface Area | 134 Ų |
| Heavy Atom Count | 37 |
| Formal Charge | 0 |
| Complexity | 977 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Anti-HIV Agents
Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS. (See all compounds classified as Anti-HIV Agents.)
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]INTERMEDIATES SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
Market Place
ABOUT THIS PAGE
A Elsulfavirine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Elsulfavirine, including repackagers and relabelers. The FDA regulates Elsulfavirine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Elsulfavirine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Elsulfavirine supplier is an individual or a company that provides Elsulfavirine active pharmaceutical ingredient (API) or Elsulfavirine finished formulations upon request. The Elsulfavirine suppliers may include Elsulfavirine API manufacturers, exporters, distributors and traders.
Elsulfavirine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Elsulfavirine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Elsulfavirine GMP manufacturer or Elsulfavirine GMP API supplier for your needs.
A Elsulfavirine CoA (Certificate of Analysis) is a formal document that attests to Elsulfavirine's compliance with Elsulfavirine specifications and serves as a tool for batch-level quality control.
Elsulfavirine CoA mostly includes findings from lab analyses of a specific batch. For each Elsulfavirine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Elsulfavirine may be tested according to a variety of international standards, such as European Pharmacopoeia (Elsulfavirine EP), Elsulfavirine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Elsulfavirine USP).
LOOKING FOR A SUPPLIER?
